450 related articles for article (PubMed ID: 15033417)
21. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
[TBL] [Abstract][Full Text] [Related]
22. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes.
Aly HA; Domènech O
Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides.
Soto-Otero R; Méndez-Alvarez E; Sánchez-Iglesias S; Zubkov FI; Voskressensky LG; Varlamov AV; de Candia M; Altomare C
Biochem Pharmacol; 2008 Apr; 75(7):1526-37. PubMed ID: 18275937
[TBL] [Abstract][Full Text] [Related]
24. The "pro-apoptotic genies" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes.
Kagan VE; Tyurina YY; Bayir H; Chu CT; Kapralov AA; Vlasova II; Belikova NA; Tyurin VA; Amoscato A; Epperly M; Greenberger J; Dekosky S; Shvedova AA; Jiang J
Chem Biol Interact; 2006 Oct; 163(1-2):15-28. PubMed ID: 16797512
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity.
Diwakar L; Kenchappa RS; Annepu J; Ravindranath V
Neurochem Int; 2007 Jul; 51(1):37-46. PubMed ID: 17512091
[TBL] [Abstract][Full Text] [Related]
26. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
Wang XJ; Xu JX
Neurosci Res; 2005 Feb; 51(2):129-38. PubMed ID: 15681030
[TBL] [Abstract][Full Text] [Related]
27. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
Hermida-Ameijeiras A; Méndez-Alvarez E; Sánchez-Iglesias S; Sanmartín-Suárez C; Soto-Otero R
Neurochem Int; 2004 Jul; 45(1):103-16. PubMed ID: 15082228
[TBL] [Abstract][Full Text] [Related]
28. The changes of intracellular H2O2 are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells.
Han YW; Kim SZ; Kim SH; Park WH
Biochem Pharmacol; 2007 Mar; 73(6):863-72. PubMed ID: 17174941
[TBL] [Abstract][Full Text] [Related]
29. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.
Weinberg A; Nylander KD; Yan C; Ma L; Hsia CJ; Tyurin VA; Kagan VE; Schor NF
Brain Res; 2004 Jun; 1012(1-2):13-21. PubMed ID: 15158156
[TBL] [Abstract][Full Text] [Related]
30. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen.
Berson A; Schmets L; Fisch C; Fau D; Wolf C; Fromenty B; Deschamps D; Pessayre D
J Pharmacol Exp Ther; 1994 Jul; 270(1):167-76. PubMed ID: 8035313
[TBL] [Abstract][Full Text] [Related]
31. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells.
Wang J; Du XX; Jiang H; Xie JX
Biochem Pharmacol; 2009 Jul; 78(2):178-83. PubMed ID: 19464433
[TBL] [Abstract][Full Text] [Related]
32. Oral administration of coenzyme Q(10) prevents cytochrome c release from mitochondria induced by 1-methyl-4-phenylpyridinium ion in mouse brain synaptosomes.
Mitsumoto Y; Kobayashi S; Matsushima H; Muroyama A; Yoshimura I
Neurosci Lett; 2009 Sep; 463(1):22-5. PubMed ID: 19638300
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effects of hydrogen peroxide and ethanol on cell viability loss in PC12 cells by increase in mitochondrial permeability transition.
Lee CS; Kim YJ; Ko HH; Han ES
Biochem Pharmacol; 2005 Jul; 70(2):317-25. PubMed ID: 15927145
[TBL] [Abstract][Full Text] [Related]
34. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning.
Leak RK; Liou AK; Zigmond MJ
J Neurochem; 2006 Nov; 99(4):1151-63. PubMed ID: 16956375
[TBL] [Abstract][Full Text] [Related]
35. Potential new insights into the molecular mechanisms of methamphetamine-induced neurodegeneration.
Wrona MZ; Yang Z; Zhang F; Dryhurst G
NIDA Res Monogr; 1997; 173():146-74. PubMed ID: 9260188
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.
Saito Y; Nishio K; Ogawa Y; Kinumi T; Yoshida Y; Masuo Y; Niki E
Free Radic Biol Med; 2007 Mar; 42(5):675-85. PubMed ID: 17291991
[TBL] [Abstract][Full Text] [Related]
38. Heat shock proteins reduce toxicity of 1-methyl-4-phenylpyridinium ion in SK-N-SH cells.
Fan GH; Qi C; Chen SD
J Neurosci Res; 2005 Nov; 82(4):551-62. PubMed ID: 16235253
[TBL] [Abstract][Full Text] [Related]
39. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
